» Articles » PMID: 25650066

Disruption of CLPB is Associated with Congenital Microcephaly, Severe Encephalopathy and 3-methylglutaconic Aciduria

Abstract

Background: The heterogeneous group of 3-methylglutaconic aciduria disorders includes several inborn errors of metabolism that affect mitochondrial function through poorly understood mechanisms. We describe four newborn siblings, from a consanguineous family, who showed microcephaly, small birth weight, severe encephalopathy and 3-methylglutaconic aciduria. Their neurological examination was characterised by severe hypertonia and the induction of prolonged clonic movements of the four limbs upon minimal tactile stimulation.

Methods And Results: Using homozygosity mapping and exome sequencing, we identified a homozygous truncating mutation (p.I562Tfs*23) in CLPB segregating with the disease in this family. CLPB codes for a member of the family of ATPases associated with various cellular activities (AAA(+) proteins) whose function remains unknown. We found that CLPB expression is abolished in fibroblasts from the patients. To investigate the function of this gene, we interfered with the translation of the zebrafish clpb orthologue using an antisense morpholino. The clpb morphants showed an abnormal touch-evoked response with increased swim velocity and tail beat frequency. This motor phenotype is reminiscent of that observed in the patients and is suggestive of increased excitability in neuronal circuits. Interestingly, knocking down clpb reduced the number of inhibitory glycinergic interneurons and increased a population of excitatory glutamatergic neurons in the spinal cord.

Conclusions: Altogether, our study suggests that disruption of CLPB causes a novel form of neonatal encephalopathy associated with 3-methylglutaconic aciduria.

Citing Articles

Mitochondrial CLPB is a pro-survival factor at the onset of granulocytic differentiation of mouse myeloblastic cells.

Wenta T, Wang G, Van Buren T, Zolkiewski M, Zolkiewska A Apoptosis. 2024; 30(1-2):334-348.

PMID: 39644357 DOI: 10.1007/s10495-024-02053-1.


Molecular Chaperones as Therapeutic Target: Hallmark of Neurodegenerative Disorders.

Sharma A, Shah O, Sharma L, Gulati M, Behl T, Khalid A Mol Neurobiol. 2023; 61(7):4750-4767.

PMID: 38127187 DOI: 10.1007/s12035-023-03846-2.


Dodecamer assembly of a metazoan AAA chaperone couples substrate extraction to refolding.

Gupta A, Lentzsch A, Siegel A, Yu Z, Chio U, Cheng Y Sci Adv. 2023; 9(19):eadf5336.

PMID: 37163603 PMC: 10171807. DOI: 10.1126/sciadv.adf5336.


Structural basis of impaired disaggregase function in the oxidation-sensitive SKD3 mutant causing 3-methylglutaconic aciduria.

Lee S, Lee S, Sung N, Xu W, Chang C, Kim H Nat Commun. 2023; 14(1):2028.

PMID: 37041140 PMC: 10090083. DOI: 10.1038/s41467-023-37657-9.


Comprehensive structural characterization of the human AAA+ disaggregase CLPB in the apo- and substrate-bound states reveals a unique mode of action driven by oligomerization.

Wu D, Liu Y, Dai Y, Wang G, Lu G, Chen Y PLoS Biol. 2023; 21(2):e3001987.

PMID: 36745679 PMC: 9934407. DOI: 10.1371/journal.pbio.3001987.